ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Divestment of rights to Alvesco, Omnaris and Zetonna to Covis Pharma
worldpharmanews
November 10, 2018AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal -
Divestment of rights to Alvesco, Omnaris and Zetonna to Covis Pharma
worldpharmanews
November 10, 2018AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal
Pharma Sources Insight January 2025
